Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 29 symbols : Snynf save search
Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
Published: 2022-03-29 (Crawled : 18:00) - biospace.com/
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: 1.35%
H: 0.15%
C: -2.33%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 1.83%
H: 3.58%
C: 1.77%
covid-19 authorization vaccine order emergency use authorization
Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab
Published: 2022-03-29 (Crawled : 13:20) - biospace.com/
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
potential sanofi antibody
Lannett Initiates Pivotal Clinical Trial For Biosimilar Insulin Glargine
Published: 2022-03-29 (Crawled : 12:00) - biospace.com/
LCI | $0.6855 0.0% 19K
|
Health Technology
|
| O: -2.51%
H: 9.62%
C: 5.76%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
trial insulin glargine biosimilar lantus
IGM Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-29 (Crawled : 11:00) - globenewswire.com
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
IGMS | News | $8.1 -11.96% -13.58% 250K
|
Health Technology
|
| O: 42.23%
H: 68.76%
C: 38.32%
results
Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets
Published: 2022-03-29 (Crawled : 09:00) - biospace.com/
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
IGMS | News | $8.1 -11.96% -13.58% 250K
|
Health Technology
|
| O: 42.23%
H: 68.76%
C: 38.32%
collaboration immunology
XNK Therapeutics raises SEK 132 million to accelerate growth
Published: 2022-03-29 (Crawled : 07:00) - prnewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
therapeutics growth
IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement with Sanofi
Published: 2022-03-29 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
IGMS | News | $8.1 -11.96% -13.58% 250K
|
Health Technology
|
| O: 42.23%
H: 68.76%
C: 38.32%
conference collaboration
Civica is Rallying Leaders to Make Insulin Affordable by 2024
Published: 2022-03-29 (Crawled : 05:00) - biospace.com/
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
insulin
Press Release: Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilumab) as key driver
Published: 2022-03-29 (Crawled : 02:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
REGN | $901.27 0.8% 0.78% 470K
|
Health Technology
|
| O: -0.12%
H: 0.93%
C: 0.85%
dupixent immunology
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.